Patients With SAT or LT After Stent Implantation (PCI) Clinical Trial
Official title:
Molecular and Cellular Mechanisms of the In-stent-thrombosis. Is it Possible to Predict a In-stent-thrombosis Using Biomarkers?
Verified date | September 2015 |
Source | RWTH Aachen University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Germany: Ethics Commission |
Study type | Observational |
In-Stent-Thrombosis is a rare but serious complication after implantation of stents during PTCA.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | May 2010 |
Est. primary completion date | May 2010 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - patients having developed an SAT or LT after stent implantation using PTCA Exclusion Criteria: - instabel coronary heart diseases, - systemic autoimmune diseases, - rheumatic diseases, - tumors, - impaired kidney or liver function, - surgery within the last 3 months, - pregnant or lactating women |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Germany | RWTH University Hospital | Aachen |
Lead Sponsor | Collaborator |
---|---|
RWTH Aachen University |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The aim of this study is to establish diagnostic markers for prediction of SAT and LT, respectively, by identification of CD39 and CD73-activity and EPC-number and function, respectively. | may 08 to may 2010 | No |